Document Report Card

Basic Information

ID: ALA1134849

Journal: Bioorg Med Chem Lett

Title: Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modification.

Authors: Song Y, Clizbe L, Bhakta C, Teng W, Li W, Wong P, Huang B, Sinha U, Park G, Reed A, Scarborough RM, Zhu BY.

Abstract: To overcome the low bioavailability of our substituted acrylamide P1 benzamidine factor Xa inhibitors reported previously, neutral and less basic groups were used to replace the benzamidine. As a result, a series of P1 aminoisoquinoline substituted acrylamide Xa inhibitors was identified to be potent, selective, and orally bioavailable. Modification of P4 moiety of these compounds further improved their pharmacokinetic properties.

CiteXplore: 12113838

DOI: 10.1016/s0960-894x(02)00304-9